Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel.
The interaction of quinidine with a cloned human cardiac potassium channel (HK2) expressed in a stable mouse L cell line was studied using the whole-cell tight-seal voltage-clamp technique. Quinidine (20 microM) did not affect the initial sigmoidal activation time course of the current. However, it reduced the peak current and induced a subsequent decline, with a time constant of 8.2 +/- 0.8 msec, to 28 +/- 6% of control (at +60 mV). The concentration dependence of HK2 block at +60 mV yielded an apparent KD of 6 microM and a Hill coefficient of 0.9. The degree of block was voltage dependent. Block increased from 0.60 +/- 0.09 at 0 mV to 0.72 +/- 0.06 at +60 mV with 20 microM quinidine and from 0.39 +/- 0.20 to 0.48 +/- 0.16 with 6 microM. Paired analysis in seven experiments with 20 microM quinidine indicated that the voltage-dependent increase in block was significant (difference, 12 +/- 4%; p less than 0.001). This voltage dependence was described by an equivalent electrical distance delta of 0.19 +/- 0.02, which suggested that at the binding site quinidine experienced 19% of the applied transmembrane electrical field, referenced to the inner surface. Quinidine reduced the tail current amplitude and slowed the time course relative to control, resulting in a "crossover" phenomenon. These data indicate that 1) the charged form of quinidine blocks the HK2 channel after it opens, 2) binding occurs within the transmembrane electrical field (probably in or near the ion permeation pathway), and 3) unbinding is required before the channel can close.
Snyders
J
J
Department of Medicine, Vanderbilt University, Nashville, Tennessee 37232-2171.
Knoth
K M
KM
Roberds
S L
SL
Tamkun
M M
MM
D000595:Amino Acid Sequence; D000818:Animals; D003001:Cloning, Molecular; D006321:Heart / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007700:Kinetics; D007739:L Cells; D008564:Membrane Potentials / Q000187:drug effects; D051379:Mice; D008969:Molecular Sequence Data; D009206:Myocardium / Q000166:cytology / Q000648:ultrastructure*; D011188:Potassium / Q000378:metabolism / Q000502:physiology; D015221:Potassium Channels / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D011802:Quinidine / Q000494:pharmacology*; D011955:Receptors, Drug / Q000187:drug effects / Q000378:metabolism; D019789:Tetraethylammonium; D013757:Tetraethylammonium Compounds / Q000378:metabolism; D013997:Time Factors; D014162:Transfection
D015221:Potassium Channels; D011955:Receptors, Drug; D013757:Tetraethylammonium Compounds; D019789:Tetraethylammonium; D011802:Quinidine; D011188:Potassium